Prevention of hepatitis C virus in hemodialysis patients: five years experience from a single center

Area of Science:

• Nephrology
• Infectious Diseases
• Hepatology

Background:

• Hepatitis C virus (HCV) poses significant risks to hemodialysis (HD) patients, leading to severe liver complications.
• Managing HCV in HD settings is crucial due to high morbidity, including cirrhosis, liver failure, and hepatoma.

Purpose of the Study:

• To evaluate the effectiveness of stringent infection control measures in preventing HCV transmission among hemodialysis patients.
• To assess HCV seroconversion rates in a cohort of seronegative HD patients over a five-year period.

Main Methods:

• The study included 36 seronegative HD patients managed under strict infection control protocols.
• HCV-positive patients were isolated, and transfusions were minimized; patients received iron and erythropoietin therapy.
• Follow-up was conducted over five years to monitor for HCV seroconversion.

Main Results:

• No cases of HCV seroconversion were observed in the study cohort over the five-year follow-up period.
• The implemented infection control strategies, including patient isolation, were highly effective in preventing viral transmission.
• Minimizing blood transfusions and appropriate patient management contributed to the zero-incidence outcome.

Conclusions:

• Strict adherence to infection control guidelines and isolation of HCV-positive patients are vital for preventing HCV transmission in hemodialysis units.
• Minimizing blood transfusions is a key strategy in reducing HCV exposure risk for HD patients.
• These measures collectively ensure patient safety and prevent outbreaks in vulnerable hemodialysis populations.